Compare Lupin with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DR. REDDYS LAB LUPIN/
DR. REDDYS LAB
 
P/E (TTM) x -62.9 37.5 - View Chart
P/BV x 3.0 4.0 73.3% View Chart
Dividend Yield % 0.7 0.6 124.6%  

Financials

 LUPIN   DR. REDDYS LAB
EQUITY SHARE DATA
    LUPIN
Mar-21
DR. REDDYS LAB
Mar-21
LUPIN/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,1225,515 20.3%   
Low Rs5763,028 19.0%   
Sales per share (Unadj.) Rs334.21,145.4 29.2%  
Earnings per share (Unadj.) Rs27.0114.5 23.6%  
Cash flow per share (Unadj.) Rs46.6188.4 24.7%  
Dividends per share (Unadj.) Rs6.5025.00 26.0%  
Avg Dividend yield %0.80.6 130.8%  
Book value per share (Unadj.) Rs300.11,053.2 28.5%  
Shares outstanding (eoy) m453.68166.30 272.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.53.7 68.1%   
Avg P/E ratio x31.437.3 84.1%  
P/CF ratio (eoy) x18.222.7 80.3%  
Price / Book Value ratio x2.84.1 69.8%  
Dividend payout %24.021.8 110.1%   
Avg Mkt Cap Rs m385,072710,289 54.2%   
No. of employees `000NANA-   
Total wages/salary Rs m28,25936,299 77.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,630190,475 79.6%  
Other income Rs m1,3632,914 46.8%   
Total revenues Rs m152,993193,389 79.1%   
Gross profit Rs m25,66938,699 66.3%  
Depreciation Rs m8,87412,288 72.2%   
Interest Rs m1,406970 145.0%   
Profit before tax Rs m16,75128,355 59.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,4859,319 48.1%   
Profit after tax Rs m12,26619,036 64.4%  
Gross profit margin %16.920.3 83.3%  
Effective tax rate %26.832.9 81.5%   
Net profit margin %8.110.0 80.9%  
BALANCE SHEET DATA
Current assets Rs m139,864145,503 96.1%   
Current liabilities Rs m84,36181,038 104.1%   
Net working cap to sales %36.633.8 108.2%  
Current ratio x1.71.8 92.3%  
Inventory Days Days6961 112.8%  
Debtors Days Days10895 113.2%  
Net fixed assets Rs m94,439109,979 85.9%   
Share capital Rs m907832 109.1%   
"Free" reserves Rs m135,229174,319 77.6%   
Net worth Rs m136,136175,151 77.7%   
Long term debt Rs m1616,299 2.6%   
Total assets Rs m234,302255,482 91.7%  
Interest coverage x12.930.2 42.7%   
Debt to equity ratio x00 3.3%  
Sales to assets ratio x0.60.7 86.8%   
Return on assets %5.87.8 74.5%  
Return on equity %9.010.9 82.9%  
Return on capital %13.316.2 82.4%  
Exports to sales %051.3 0.0%   
Imports to sales %018.1 0.0%   
Exports (fob) Rs mNA97,699 0.0%   
Imports (cif) Rs mNA34,420 0.0%   
Fx inflow Rs m51,02797,699 52.2%   
Fx outflow Rs m21,08134,420 61.2%   
Net fx Rs m29,94663,279 47.3%   
CASH FLOW
From Operations Rs m18,21835,703 51.0%  
From Investments Rs m-12,396-22,660 54.7%  
From Financial Activity Rs m-18,853-298 6,326.4%  
Net Cashflow Rs m-13,03112,858 -101.3%  

Share Holding

Indian Promoters % 46.5 26.7 174.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 40.4 49.7 81.3%  
FIIs % 15.3 27.4 55.7%  
ADR/GDR % 0.0 11.5 -  
Free float % 53.2 61.8 86.1%  
Shareholders   361,862 242,376 149.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    CADILA HEALTHCARE    PIRAMAL ENTERPRISES    



Today's Market

Sensex Sheds 581 Points, Nifty Ends Near 17,100; HCL Tech & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

LUPIN 2020-21 Annual Report Analysis (Annual Result Update)

Oct 19, 2021 | Updated on Oct 19, 2021

Here's an analysis of the annual report of LUPIN for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

Dr Reddy's New Covid-19 Treatment Option Puts Stock in Focus (Views On News)

May 24, 2021

With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jan 27, 2022 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS